124 results on '"Portincasa Piero"'
Search Results
2. Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review
3. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability
4. Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography
5. Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
6. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
7. Genetic and clinical features of familial mediterranean fever (FMF) in a homogeneous cohort of patients from South-Eastern Italy
8. Nuclear and chromatin rearrangement associate to epigenome and gene expression changes in a model of in vitro adipogenesis and hypertrophy
9. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease
10. Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age
11. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver
12. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle
13. Hepatic consequences of COVID-19 infection. Lapping or biting?
14. Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances
15. Cholecystectomy and risk of metabolic syndrome
16. Obesity phenotypes and their paradoxical association with cardiovascular diseases
17. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile
18. The fatty liver as testimonial of systemic diseases. Further evidence from rheumatoid arthritis and confirmation for a leading role of internal medicine
19. AMA-positivity in AIH-patients with bile duct lesions running in between. Novel findings and perspectives
20. Cholesterol gallstone disease
21. Extent and features of liver steatosis in vitro pave the way to endothelial dysfunction without physical cell-to-cell contact.
22. Corrigendum to ‘Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.’ [European Journal of Internal Medicine 89C (2021) 56–64]
23. Water handling and aquaporins in bile formation: recent advances and research trends
24. Mitochondrial glutathione content determines the rate of liver regeneration after partial hepatectomy in eu- and hypothyroid rats
25. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients
26. Supplementation with Thymbra spicata extract ameliorates lifespan, body-weight gain and Paraquat-induced oxidative stress in Drosophila melanogaster: An age- and sex-related study.
27. Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy
28. Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo
29. Biomechanics of cultured hepatic cells during different steatogenic hits.
30. Phytocompounds modulating Aquaporins: Clinical benefits are anticipated.
31. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients.
32. Micellar lipid composition profoundly affects LXR-dependent cholesterol transport across CaCo2 cells
33. Assessing the nutritional status of older individuals in family practice: Evaluation and implications for management.
34. Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders.
35. Obesity and the risk and prognosis of gallstone disease and pancreatitis.
36. Loss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome.
37. Cholecystectomy: a way forward and back to metabolic syndrome?
38. Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF).
39. Unraveling the beneficial effects of herbal Lebanese mixture "Za'atar". History, studies, and properties of a potential healthy food ingredient.
40. Water channel proteins in bile formation and flow in health and disease: When immiscible becomes miscible
41. Management of chronic liver disease by general practitioners in Southern Italy: Unmet educational needs.
42. Nonalcoholic fatty liver disease.
43. 13C-octanoic acid breath test (OBT) with a new test meal (EXPIROGer®): Toward standardization for testing gastric emptying of solids.
44. Dietary Choline Deprivation Impairs Rat Brain Mitochondrial Function and Behavioral Phenotype.
45. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
46. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice
47. Role of Sumac (Rhus coriaria L.) in the management of metabolic syndrome and related disorders: Focus on NAFLD-atherosclerosis interplay.
48. Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms
49. Effect of Ezetimibe on the Prevention and Dissolution of Cholesterol Gallstones.
50. Mitochondrial dysfunction in rat with nonalcoholic fatty liver: Involvement of complex I, reactive oxygen species and cardiolipin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.